Groundbreaking new research has uncovered a potential route to developing the first ever drug treatments for vascular dementia, that directly target a cause of the condition. The research, funded by us and published in the journal Proceedings of the National Academy of Sciences, has shed light on how high blood pressure causes changes to arteries in the brain, a process that leads to the devastating condition.
